Did you know that you can buy products from over 140 different suppliers from us?

Alpha2, 6-Sialyltransferase antibody

Details for Product No. ABIN195493
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Antigen
Reactivity
Human, Mouse (Murine), Rat (Rattus)
(3), (1)
Host
Rabbit
(4)
Clonality
Polyclonal
Application
Western Blotting (WB)
(4)
Pubmed 4 references available
Quantity 100 µg
Shipping to United States (Change)
Availability Will be delivered in 8 to 11 Business Days
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Catalog No. ABIN195493
618.20 $
Plus shipping costs $45.00

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Immunogen Synthetic peptide of a part of alpha2, 6-sialyltransferase (NSQLVTTEKRFLKDSL) (the part common to human, mouse and rat)
Isotype IgG
Specificity Reacts with Human, Mouse, Rat alpha2, 6-sialyltransferase
Purification Purified with antigen peptide
Alternative Name alpha2, 6-Sialyltransferase (M2)
Background The histopathological picture of Alzheimer’s disease is characterized by senile plaques and neurofibrillary tangles, and because the senile plaques form first, they are considered the initial lesion. Senile plaques are known to be formed by accumulation of ?-amyloid peptide (A?). A? peptide is produced by the cleavage of amyloid precursor protein (APP) by two types of proteolytic enzymes. The first cleavage is performed by ?-secretase (BACE1), and the second ?-secretase. It is thought that their inhibitors may be capable of serving as safe drugs for the treatment of Alzheimer’s disease. In recent years a glycosyltransferase involved in the biosynthesis of sugar chains (?2, 6-sialyltransferase) has also been shown to be cleaved by BACE1. The cleavage site was identified at the same time, and as a result it was demonstrated that in rats it produces cleavaged-type ?2, 6-sialyltransferase (E41 Form). This product is purified antibody which can detect human, mouse or rat ?2, 6-sialyltransferase whether or not it is cleavaged.
Research Area Alzheimer's Disease
Application Notes Western blotting in concentration of 1 – 5ug/mL
Restrictions For Research Use only
Format Lyophilized
Buffer Lyophilized product from 1% BSA in PBS containing 0.05% NaN3
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C
Supplier Images
anti-Alpha2, 6-Sialyltransferase antibody anti-Alpha2, 6-Sialyltransferase antibody
General Kitazume-Kawaguchi, Dohmae, Takio et al.: "The relationship between ST6Gal I Golgi retention and its cleavage-secretion." in: Glycobiology, Vol. 9, Issue 12, pp. 1397-406, 2000 (PubMed).

Kitazume, Tachida, Oka et al.: "Alzheimer's beta-secretase, beta-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, Issue 24, pp. 13554-9, 2001 (PubMed).

Kitazume, Saido, Hashimoto: "[Identification of a novel substrate of Alzheimer's beta-secretase: beta-secretase dependent cleavage of alpha 2,6 sialyltransferase]" in: Seikagaku. The Journal of Japanese Biochemical Society, Vol. 74, Issue 9, pp. 1180-3, 2002 (PubMed).

Kitazume, Tachida, Oka et al.: "Characterization of alpha 2,6-sialyltransferase cleavage by Alzheimer's beta -secretase (BACE1)." in: The Journal of biological chemistry, Vol. 278, Issue 17, pp. 14865-71, 2003 (PubMed).

Validation Images
back to top